RU97110400A - METHOD FOR PREVENTION AND TREATMENT OF PATIENTS SUFFERING WITH ESTROGEN- AND ANDROGEN-DEPENDENT TUMORS - Google Patents

METHOD FOR PREVENTION AND TREATMENT OF PATIENTS SUFFERING WITH ESTROGEN- AND ANDROGEN-DEPENDENT TUMORS

Info

Publication number
RU97110400A
RU97110400A RU97110400/14A RU97110400A RU97110400A RU 97110400 A RU97110400 A RU 97110400A RU 97110400/14 A RU97110400/14 A RU 97110400/14A RU 97110400 A RU97110400 A RU 97110400A RU 97110400 A RU97110400 A RU 97110400A
Authority
RU
Russia
Prior art keywords
prevention
treatment
androgen
estrogen
patients suffering
Prior art date
Application number
RU97110400/14A
Other languages
Russian (ru)
Other versions
RU2163812C2 (en
Inventor
А.П. Бахтинов
Original Assignee
Брянский государственный педагогический университет имени академика И.Г.Петровского
Filing date
Publication date
Application filed by Брянский государственный педагогический университет имени академика И.Г.Петровского filed Critical Брянский государственный педагогический университет имени академика И.Г.Петровского
Priority to RU97110400A priority Critical patent/RU2163812C2/en
Priority claimed from RU97110400A external-priority patent/RU2163812C2/en
Publication of RU97110400A publication Critical patent/RU97110400A/en
Application granted granted Critical
Publication of RU2163812C2 publication Critical patent/RU2163812C2/en

Links

Claims (1)

Способ профилактики и лечения больных, страдающих эстрогено- и андрогенозависимыми опухолями, включающий введение в организм антигормонов, отличающийся тем, что в качестве антигормонов используют антиэстрогенный и антиандрогенный препарат, дозу которого 1,2-1,5 мг перед употреблением растворяют в 3 мл 0,9% раствора хлорида натрия, вводят ежедневно в течение 30-40 дней и при необходимости курс профилактики и лечения повторяют через 3-4 месяца.A method for the prevention and treatment of patients suffering from estrogen- and androgen-dependent tumors, including the introduction of antihormones into the body, characterized in that antiestrogens and antiandrogenic drugs are used, the dose of which is 1.2-1.5 mg, dissolved in 3 ml before use, 9% sodium chloride solution is administered daily for 30-40 days and, if necessary, the course of prevention and treatment is repeated after 3-4 months.
RU97110400A 1997-06-17 1997-06-17 Method of prophylaxis and treatment of patients suffering with estrogen- and androgen-dependent tumors RU2163812C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97110400A RU2163812C2 (en) 1997-06-17 1997-06-17 Method of prophylaxis and treatment of patients suffering with estrogen- and androgen-dependent tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97110400A RU2163812C2 (en) 1997-06-17 1997-06-17 Method of prophylaxis and treatment of patients suffering with estrogen- and androgen-dependent tumors

Publications (2)

Publication Number Publication Date
RU97110400A true RU97110400A (en) 1999-05-27
RU2163812C2 RU2163812C2 (en) 2001-03-10

Family

ID=20194377

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97110400A RU2163812C2 (en) 1997-06-17 1997-06-17 Method of prophylaxis and treatment of patients suffering with estrogen- and androgen-dependent tumors

Country Status (1)

Country Link
RU (1) RU2163812C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2597779C2 (en) * 2014-06-26 2016-09-20 Анатолий Петрович Бахтинов Version of the method for preventing and treating individuals suffering from estrogen-and androgen-dependent tumors

Similar Documents

Publication Publication Date Title
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
TR199801180T2 (en) New compounds with analgesic effect.
IS1858B (en) Method of producing a pharmaceutical composition in the form of pellets for the treatment of intestinal inflammation
RU95101385A (en) Products containing g-csf and tnf-binding protein
DE69733089D1 (en) Treatment of osteotarthritis by administration of poly-N-acetyl-D-glucosamine
UA32457C2 (en) Drug (variants) and methods for exposure to drug
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
TR199801184T2 (en) New compounds with analgesic action.
RU97110400A (en) METHOD FOR PREVENTION AND TREATMENT OF PATIENTS SUFFERING WITH ESTROGEN- AND ANDROGEN-DEPENDENT TUMORS
RU93052161A (en) MEDICINES CONTAINING IMIDAZOLE-1-ILA DERIVATIVES
EP0835662A3 (en) A drug for the treatment of cancer
RU2002103808A (en) METHOD FOR TREATING PAIN SYNDROME IN ONCOLOGIC PATIENTS
BE1002256A3 (en) DRUGS.
KR900017599A (en) Pharmaceutical composition for tumor treatment
CA2197139A1 (en) A drug for the treatment of cancer
SE9700617D0 (en) New composition
Bhatt et al. Oral absorption of metronidazole in rabbits irradiated with cobalt‐60 gamma radiation
RU98109810A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU2000103385A (en) METHOD FOR TREATING ACUTE PANCREOTITIS
RU2000117880A (en) METHOD FOR TREATING PATIENTS WITH POLYORGANIC DEFICIENCY
EA199700025A1 (en) APPLICATION OF OLIGOSACCHARIDE AND ASPIRIN TO PREPARATION OF MEDICINES INTENDED FOR THE TREATMENT OF THROMBOEMBOLIC DISEASES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
RU97110383A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU99104916A (en) METHOD FOR TREATING PATIENTS WITH Nonspecific ulcerative colitis
RU99127981A (en) METHOD FOR TREATMENT OF REFRESHING FURUNCULOSIS